Pharmaceutical Software Development Company for Validated, HIPAA Compliant Systems

Custom pharmaceutical software costs between $75,000 and $350,000 for the initial build. A single module such as a dispensing portal or adverse event intake tool runs $75,000 to $120,000. A departmental system such as a full pharmacovigilance or pharmacy management platform runs $120,000 to $220,000. A multi system platform with several regulated integrations and full GAMP 5 validation runs $220,000 to $350,000 and above. Annual maintenance is 15 to 20 percent of the build cost. We set a fixed price only after discovery has produced the functional specification.

A single module takes 3 to 5 months from discovery to deployment. A departmental system takes 5 to 9 months. A multi system platform with ERP, EHR and safety database integrations takes 8 to 14 months. Discovery itself takes two to four weeks. Validation runs in parallel with development, so it adds documentation effort rather than calendar time at the end.

21 CFR Part 11 requires four things of a system that handles electronic records in an FDA regulated process. The system is validated. It keeps secure, computer generated, time stamped audit trails that record the creation, modification and deletion of records without hiding earlier values. Access is limited to authorized individuals with unique credentials. Electronic signatures are bound to their records and show the signer's printed name, the date and time, and the meaning of the signature. We design these controls into the data model and authentication layer at the architecture stage and document them in the validation package.

HIPAA applies whenever the software creates, receives, stores or transmits protected health information on behalf of a covered entity or business associate. Pharmacy dispensing systems, patient support programs, trial participant portals that pull from provider records, and adverse event systems holding identifiable patient details all fall inside it. Manufacturing quality and inventory systems with no patient data generally do not. We assess applicability during discovery. Where HIPAA applies, we build to the Security Rule's administrative, physical and technical safeguards and sign a business associate agreement.

Buy a platform when your process is standard for your category, the vendor's validation package satisfies your quality unit, you have a small user count, and the vendor's integrations already cover your systems. Build custom when the workflow is a competitive advantage, you need integrations the vendor does not offer, licence fees across users and sites will exceed the cost of ownership within two to three years, or you plan to sell the system as a product and need to own the intellectual property. Many pharma companies keep a platform for one validated function and have us build the modules around it.

Each regulated build ships with a validation plan, user and functional requirements specifications, a GAMP 5 risk assessment, a requirements traceability matrix, executed installation, operational and performance qualification protocols with signed results, and a validation summary report. The package follows FDA's Computer Software Assurance guidance, so testing depth matches patient safety and product quality risk rather than being uniform across every screen.

We integrate with Surescripts for electronic prescribing, Veeva Vault and Veeva CRM, Medidata Rave and other EDC platforms, Oracle Argus and other safety databases, SAP S/4HANA, Oracle NetSuite and Microsoft Dynamics 365 for ERP, Salesforce, Epic, Oracle Health and athenahealth EHRs, and wholesaler EDI connections. We work in HL7 FHIR R4, HL7 v2, NCPDP SCRIPT, X12 837 and 835, CDISC ODM and SDTM, ICH E2B(R3) and GS1 EPCIS for DSCSA.

Yes, when the AI feature is scoped so that a qualified person reviews and approves its output before the record is final, and when the model's inputs, outputs and version are logged. We use AI for adverse event triage, trial recruitment and retention scoring, batch deviation prediction, drafting of regulatory and medical documents from approved sources, demand forecasting and HCP engagement analytics. Each feature is risk assessed under GAMP 5 like any other function, so it does not weaken the system's validated state.

You do. Source code, data models, documentation and validation deliverables are assigned to your organization on payment. This matters most for pharma services and health technology companies building a product to sell into manufacturers, CROs or pharmacies. Ownership of the code is a condition of the exit or licensing deals those companies pursue.

Start with a scoping call. After that we propose a discovery phase of two to four weeks. Discovery produces the functional specification, integration map, regulatory applicability assessment and validation approach, and we quote a fixed price against that document. You keep the discovery deliverables whether or not you proceed to development with us. We have worked only in healthcare since 2011 and hold the GHP Global Excellence Award for Best Custom Healthcare Software Development Company for 2024, 2025 and 2026.